Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Comorbid PTSD and AUD
NCT02884908Phase 3Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), sponsored by University of Maryland, Baltimore. Started Jul 2017; status: completed.
02
Drugs
pregabalin
03
Conditions
alcohol use disorder (AUD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02884908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02884908.